Valproic Acid and Levocarnitine ( DrugBank: Valproic acid, Levocarnitine )

---

1 disease

ID	Disease name (Link within this page)	Number of trials
3	Spinal muscular atrophy	2

3. Spinal muscular atrophy

---

Clinical trials : 217 /  Drugs : 149 - (DrugBank : 33) / Drug target genes : 54 - Drug target pathways : 80

No.	TrialID	Date_ enrollment	Date_ registration	Public_title	Scientific_title	Condition	Intervention	Primary_ sponsor	Secondary_ sponsor	Recruitment_ Status	Inclusion_ agemin	Inclusion_ agemax	Inclusion_ gender	Target_ size	Phase	Countries
1	NCT00661453 (ClinicalTrials.gov)	April 2008	14/4/2008	CARNIVAL Type I: Valproic Acid and Carnitine in Infants With Spinal Muscular Atrophy (SMA) Type I	Phase I/II Trial of Valproic Acid and Carnitine in Infants With Spinal Muscular Atrophy Type I (CARNI-VAL Type I)	Spinal Muscular Atrophy Type I	Drug: Valproic Acid and Levocarnitine	University of Utah	Families of Spinal Muscular Atrophy;Leadiant Biosciences, Inc.	Completed	N/A	12 Months	All	40	Phase 1/Phase 2	United States;Canada;Germany
2	NCT00227266 (ClinicalTrials.gov)	September 2005	23/9/2005	Valproic Acid and Carnitine in Patients With Spinal Muscular Atrophy	Multi-center Phase II Trial of Valproic Acid and Carnitine in Patients With Spinal Muscular Atrophy (SMA CARNI-VAL Trial)	Spinal Muscular Atrophy	Drug: Valproic Acid and Levocarnitine;Drug: Placebo	University of Utah	Families of Spinal Muscular Atrophy;Leadiant Biosciences, Inc.;Abbott	Completed	2 Years	17 Years	All	94	Phase 2	United States;Canada